Methods viable immunotherapy adoptive. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy30

T-Lymphocytes, Cytotoxic Dendritic Cells T-Lymphocytes Lymphocytes, Tumor-Infiltrating CD8-Positive T-Lymphocytes Pollen Cytokine-Induced Killer Cells Cell Line, Tumor CD4-Positive T-Lymphocytes Killer Cells, Natural T-Lymphocytes, Regulatory Killer Cells, Lymphokine-Activated Tumor Cells, Cultured Antigen-Presenting Cells T-Lymphocyte Subsets Leukocytes, Mononuclear Cells, Cultured Spleen Basophils K562 Cells Th1 Cells Immune System B-Lymphocytes Lymph Nodes Myeloid Cells Lymphocytes Th2 Cells Cell Line Clone Cells T-Lymphocytes, Helper-Inducer

Organisms19

Mice, Inbred C57BL Mice, Inbred BALB C Mice, Transgenic Pyroglyphidae Cryptomeria Hymenoptera Poaceae Mice, SCID Mites Betula Dermatophagoides pteronyssinus Phleum Parietaria Propionibacterium acnes Arachis hypogaea Adenoviridae Mice, Inbred NOD Mycobacterium bovis Mice, Knockout

Diseases44

Rhinitis, Allergic, Seasonal Neoplasms Melanoma Melanoma, Experimental Hypersensitivity Insect Bites and Stings Rhinitis, Allergic, Perennial Neoplasms, Experimental Kidney Neoplasms Carcinoma, Renal Cell Anaphylaxis Peanut Hypersensitivity Disease Models, Animal Skin Neoplasms Sarcoma, Experimental Conjunctivitis, Allergic Fibrosarcoma Lung Neoplasms Neoplasm Metastasis Food Hypersensitivity Brain Neoplasms Nut Hypersensitivity Egg Hypersensitivity Sneezing Remission, Spontaneous Lymphoma Prostatic Neoplasms Carcinoma, Lewis Lung Lymphoma, B-Cell Colonic Neoplasms Autoimmune Diseases Asthma Vitiligo Anti-N-Methyl-D-Aspartate Receptor Encephalitis Multiple Myeloma Urinary Bladder Neoplasms Hypersensitivity, Immediate Ovarian Neoplasms Leukemia Glioma Hypersensitivity, Delayed Neoplasm Regression, Spontaneous Nasal Obstruction Glioblastoma

Chemicals and Drugs91

Cancer Vaccines Antigens, Neoplasm Allergens Interleukin-2 Antibodies, Monoclonal HLA-A2 Antigen Bee Venoms Immunoglobulin E Antigens, Plant BCG Vaccine Alzheimer Vaccines HLA-A24 Antigen Epitopes, T-Lymphocyte Adjuvants, Immunologic Interferon-gamma Antibodies, Neoplasm HLA-A Antigens Melanoma-Specific Antigens gp100 Melanoma Antigen Picibanil Wasp Venoms MART-1 Antigen Cytokines Epitopes Antibodies, Bispecific Neoplasm Proteins Immunologic Factors Vaccines, Subunit Vaccines Immunoglobulin G Antigens, Dermatophagoides Antigens, CD Antibodies Antineoplastic Agents CTLA-4 Antigen Recombinant Proteins Receptors, Antigen, T-Cell Peptide Fragments Vaccines, DNA Antigens, CD80 Interleukin-12 Granulocyte-Macrophage Colony-Stimulating Factor Membrane Glycoproteins Antigens, CD3 Antigens, CD20 Mucin-1 Peptides Tissue Extracts Antigens, CD40 Programmed Cell Death 1 Receptor Receptors, Antigen Ovalbumin Interferon-alpha Recombinant Fusion Proteins Antigens, CD274 Antigens, CD137 Histocompatibility Antigens Class I Antibodies, Anti-Idiotypic Papillomavirus E7 Proteins Antigens Interleukin-10 Immunoconjugates Amyloid beta-Peptides Antigens, Tumor-Associated, Carbohydrate Interleukin-15 Anti-Allergic Agents Antibodies, Monoclonal, Murine-Derived Antigens, CD19 Immunoglobulin Idiotypes HLA-A1 Antigen Antibodies, Blocking Autoantigens Interleukin-2 Receptor alpha Subunit Interleukin-4 4-1BB Ligand Immunoglobulin Fragments Immunoglobulins, Intravenous Cyclophosphamide CD40 Ligand Perforin GPI-Linked Proteins Antigens, Surface Transfer Factor Minor Histocompatibility Antigens Antigens, CD28 Single-Chain Antibodies Receptors, IgG RNA, Messenger Methylcholanthrene Pore Forming Cytotoxic Proteins Arthropod Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment48

Immunotherapy Immunotherapy, Adoptive Immunotherapy, Active Desensitization, Immunologic Administration, Sublingual Sublingual Immunotherapy Melanoma, Experimental Immunization, Passive Lymphocyte Activation Combined Modality Therapy Neoplasms, Experimental Clinical Trials as Topic Flow Cytometry Neoplasm Transplantation Adoptive Transfer Skin Tests Injections, Subcutaneous Treatment Outcome Disease Models, Animal Genetic Therapy Cytotoxicity Tests, Immunologic Monitoring, Immunologic Sarcoma, Experimental Immunization Enzyme-Linked Immunosorbent Assay Vaccination Injections, Intralesional Lymphocyte Depletion Transduction, Genetic Lymphocyte Transfusion Immunophenotyping Injections, Intradermal Immunomodulation Models, Immunological Coculture Techniques Transplantation, Homologous Molecular Targeted Therapy Administration, Intravesical Gene Transfer Techniques Radioallergosorbent Test Epitope Mapping Immunosuppression Injections, Intralymphatic Nasal Provocation Tests Reverse Transcriptase Polymerase Chain Reaction Cell Separation Transfection Immunohistochemistry

Phenomena and Processes29

Cytotoxicity, Immunologic Lymphocyte Activation Tumor Escape Antigen Presentation Immune Tolerance Immunity, Cellular Genetic Vectors T-Cell Antigen Receptor Specificity Transduction, Genetic Tumor Microenvironment Dose-Response Relationship, Immunologic Antibody-Dependent Cell Cytotoxicity Immunity Cell Proliferation Immunologic Surveillance Time Factors Sneezing Amino Acid Sequence Autoimmunity Immunomodulation Antibody Specificity Remission, Spontaneous Immunologic Memory Graft vs Tumor Effect Genes, T-Cell Receptor Immunoglobulin Idiotypes Graft vs Leukemia Effect Transfection Neoplasm Regression, Spontaneous

Disciplines and Occupations1

Immunohistochemistry

Technology, Industry, Agriculture2

Arachis hypogaea Artificial Cells

Information Science2

Amino Acid Sequence Molecular Sequence Data

Health Care4

Clinical Trials as Topic Treatment Outcome Immunization Vaccination

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Technology, Industry, Agriculture Information Science Health Care

Immunotherapy Immunotherapy, Adoptive Immunotherapy, Active Desensitization, Immunologic Cancer Vaccines Antigens, Neoplasm Administration, Sublingual Sublingual Immunotherapy Rhinitis, Allergic, Seasonal T-Lymphocytes, Cytotoxic Dendritic Cells Allergens Neoplasms T-Lymphocytes Melanoma Interleukin-2 Antibodies, Monoclonal Lymphocytes, Tumor-Infiltrating CD8-Positive T-Lymphocytes Melanoma, Experimental Immunization, Passive Cytotoxicity, Immunologic HLA-A2 Antigen Bee Venoms Lymphocyte Activation Mice, Inbred C57BL Pollen Tumor Escape Immunoglobulin E Antigens, Plant BCG Vaccine Alzheimer Vaccines Mice, Inbred BALB C Cytokine-Induced Killer Cells Hypersensitivity Cell Line, Tumor HLA-A24 Antigen Epitopes, T-Lymphocyte Insect Bites and Stings Rhinitis, Allergic, Perennial Adjuvants, Immunologic Interferon-gamma Antibodies, Neoplasm HLA-A Antigens Combined Modality Therapy Melanoma-Specific Antigens CD4-Positive T-Lymphocytes Neoplasms, Experimental Clinical Trials as Topic gp100 Melanoma Antigen Killer Cells, Natural Picibanil Flow Cytometry T-Lymphocytes, Regulatory Antigen Presentation Wasp Venoms Kidney Neoplasms Killer Cells, Lymphokine-Activated MART-1 Antigen Carcinoma, Renal Cell Cytokines Immune Tolerance Mice, Transgenic Pyroglyphidae Neoplasm Transplantation Adoptive Transfer Epitopes Skin Tests Cryptomeria Tumor Cells, Cultured Antibodies, Bispecific Neoplasm Proteins Immunologic Factors Injections, Subcutaneous Anaphylaxis Vaccines, Subunit Vaccines Treatment Outcome Hymenoptera Peanut Hypersensitivity Immunoglobulin G Immunity, Cellular Antigens, Dermatophagoides Antigens, CD Genetic Vectors Disease Models, Animal Genetic Therapy Antigen-Presenting Cells Cytotoxicity Tests, Immunologic Antibodies Skin Neoplasms Antineoplastic Agents CTLA-4 Antigen Recombinant Proteins T-Lymphocyte Subsets Monitoring, Immunologic Receptors, Antigen, T-Cell Sarcoma, Experimental Immunization Peptide Fragments

No FAQ available that match "methods viable immunotherapy adoptive"